A Randomized Double-Blind, Double-Dummy, Placebo-Controlled, Parallel-Group, Multicenter, Dose Ranging Study to Evaluate the Efficacy and Safety of GW685698X Inhalation Powder Once Daily and Fluticasone Propionate Inhalation powder 250mcg Twice Daily

Grants and Contracts Details

StatusFinished
Effective start/end date5/1/08 → 3/31/10

Funding

  • GlaxoSmithKline: $27,889.00